BRILINTA

Identification of Brilinta

No description

Google image searchProduct monograph

Active ingredient

ticagrelor, 60 MG

DIN: 02455005

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: ASTRAZENECA CANADA INC

Date: 13-JUN-2016

ATC:

• B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
• B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
• B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
• B01AC24 — TICAGRELOR (ATC/DDD)

Reference brand drug: Brilinta

External Links for Brilinta

Search on Google

• Brilinta side effects
• Brilinta dosage
• ticagrelor side effects
• ticagrelor dosage

Astrazeneca Canada Inc

Go to AstraZeneca website to see drug product details. Sometimes you can find brilinta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.